For the second time in less than a year, GlaxoSmithKline (GSK) is reworking promotional practices in order to boost prescriptions, and its latest move will provide greater incentives for its sales ...
Artificial intelligence research experienced a renaissance in the last twenty years as a result in part of greater computing power, the rise of the graphics processing unit, or GPU. Now, novel AI ...
GlaxoSmithKline plc GSK reported fourth-quarter 2021 adjusted earnings of 69 cents per American depositary share (“ADS”), beating the Zacks Consensus Estimate of 63 cents. Adjusted earnings were up 9% ...
LONDON, June 5 (Reuters) - GlaxoSmithKline Plc , its shares off 12 percent in the past fortnight due to a safety scare over diabetes drug Avandia, is under growing pressure to increase cash returns to ...
LONDON, April 12 (Reuters) - The failure of rival heart drugs has put the spotlight on a novel GlaxoSmithKline Plc compound that will reach a critical stage of testing this year, after languishing in ...
GlaxoSmithKline plcGSK has entered into an agreement with Novartis NVS to buy out the latter's stake in their Consumer Healthcare joint venture (JV) for $13 billion (£9.2 billion). With the ...
BOSTON (MarketWatch) -- During a hearing held by a Congressional committee looking at improving drug safety, a senior GlaxoSmithKline official defended the safety of its popular diabetes drug Avandia, ...
With over 5 million customers, genetic testing firm 23andMe sits on a trove of human data it believes can help drugmakers develop treatments more efficiently in an industry where 90% of medicines on ...
TRENTON, N.J. --Pharmaceutical giants GlaxoSmithKline PLC and Pfizer Inc. will pool their resources to create a new company to develop and sell HIV medicines, leveraging a minimal investment into a ...
GlaxoSmithKline Plc is splitting into two companies and creating a consumer-health joint venture with Pfizer Inc. that will be the world’s biggest supplier of over-the-counter medicines with brands ...
GlaxoSmithKline Plc cut its chief executive officer’s pay by 14% after the pandemic caused the company to miss targets for sales of vaccines against other diseases. Emma Walmsley’s total remuneration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback